Sign in
CompletedNo phase

Bioboosti Device for Insomnia Treatment

Key facts

Who runs it
Brigham and Women's Hospital
Where
Boston, United StatesSee the 2 sites
Trial code
Status
Completed
People taking part
20 people enrolled
Started
Sept 2016
Ended
Apr 2025
Type of study
Interventional, 3 groups
Treatments tested
  • Bioboosti
Record updated
4 March 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Patients with insomnia

Who cannot take part

  • Major circadian rhythm disorder
  • Cardiac pacemaker
  • Cancer
  • Severe conditions related to heart, brain, kidney and hematopoietic system
  • Severe/unstable angina pectoris
  • Acute congestive heart failure
  • Renal insufficiency
  • Untreated moderate or severe sleep apnea
  • Pregnant women
  • Breastfeeding
  • Arteria coronaria/ peripheral arterial bypass graft
  • Mechanical intestinal obstruction
  • Any electrical devices

Where in United States

  • Brigham and Women's Faulkner HospitalBoston, United States
  • Brigham and Women's HospitalBoston, United States

About the trial

What the trial wants to find out

The purpose of this study is to determine the effects of the Bioboosti device on sleep for patients who have been diagnosed with insomnia.

The 3 groups in the trial

  • BioboostiTreatment being tested

    Treatment with the Bioboosti device for two weeks. The device produces a pulsed micro-magnetic field. Subjects will use it once a day for about one hour, before habitual sleep time.

  • Sustained EfficacyTreatment being tested

    Treatment with Bioboosti device for a year. In order to see if the device has sustained efficacy in treating insomnia. Subjects will use it once a day for about one hour, before habitual sleep time.

    Treatment: Bioboosti

  • Insomnia and migraineTreatment being tested

    Treatment with the Bioboosti device for a month. Subjects will use it once a day for about one hour, before habitual sleep time.

    Treatment: Bioboosti

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Use of Bioboosti Non-pharmacologic Device for Insomnia Treatment: A Pilot Study
Record updated
4 March 2026